The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of chimeric antigen receptor (CAR)–T cell therapy (BRG01) targeting the Epstein-Barr virus (EBV) envelope protein in EBV+ lymphoproliferative disease patients.
 
Xinfeng Chen
No Relationships to Disclose
 
Guohui Qin
No Relationships to Disclose
 
Dan Wang
No Relationships to Disclose
 
Xudong Zhang
No Relationships to Disclose
 
Mingzhi Zhang
No Relationships to Disclose
 
Xi Zhang
Employment - Biosyngen Pte Ltd
Leadership - Biosyngen Pte Ltd
Stock and Other Ownership Interests - Biosyngen Pte Ltd
 
Deping Han
Employment - Biosyngen Pte Ltd
Leadership - Biosyngen Pte Ltd
Stock and Other Ownership Interests - Biosyngen Pte Ltd
 
Yi Zhang
No Relationships to Disclose